trastuzumab,neratinib
puma,roche
['neratinib', 'summit', 'puma']
(puma biotechnology presents up to date findings from the section ii summit basket trial of neratinib for her2-mutant, recurrent/metastatic cervical most cancers on the esmo congress 2022 enterprise wire) has been published on the globe - 